Updated: June 1, 2020

The Canadian Pharmacists Association (CPhA) is committed to working with Health Canada and the Public Health Agency of Canada (PHAC) to ensure that pharmacists across Canada have the tools and resources to support their patients as we continue to respond to the COVID-19 pandemic.

Newly Added

• Pharmacists continue to have difficulty sourcing certain medications amidst the COVID-19 pandemic
• Webinar Recordings - The Role of Pharmacy in Public and Population Health (May 20)
• CPhA appears before Standing Committee briefing on Canadian response to COVID-19
• Updated - Antiretroviral combinations
• Updated - DMARDs or other anti-rheumatic medications
• Updated - Treatment of COVID-19 with chloroquine or hydroxychloroquine
• Infographic - National survey of community pharmacists and practice challenges during COVID-19

 

---

 

• (Updated) Protecting the Front Line: COVID-19 Day-to-Day Questions: CPhA has created an FAQs resource to help pharmacists manage day-to-day questions about COVID-19 in their pharmacies. This information is meant to support policy, practice and clinical guidelines being developed across the country, and will answer key questions pharmacists may have when supporting their patients during the pandemic. The content will be updated regularly.
• Personal Protective Equipment (PPE): Suggested Best Practices for Pharmacies During the COVID-19 Pandemic: CPhA has recently updated its suggested best practices on the use of PPE by pharmacy staff. Changes reflect new guidance from health organizations in Canada and around the world on the use of non-medical masks to reduce virus spread, sessional use of PPE in certain circumstances and tools to help practitioners better assess individual scenarios where PPE may be required.
• Staffing and Business Considerations if a Pharmacy Team Member Becomes Ill: CPhA and the Neighbourhood Pharmacy Association of Canada have developed a list of key considerations for pharmacy managers/owners to help them prepare for next steps if a pharmacy staff member is exposed to or infected with COVID-19. This document will help pharmacies prepare for staff reductions or store closures and offers guidance on staff reductions, self-assessment and connecting with local public health units.
• The COVID Conversations: CPhA's open access webinar series designed to support pharmacists during the COVID-19 pandemic.
  • Webinar Recordings: Recent webinars include The Role of Pharmacy in Public and Population Health, Opioid Stewardship Under the New CDSA Exemptions, COVID-19 and the Global Experience, Supporting Pharmacists’ Mental Health and Wellness, A Day In the Life of Community Pharmacists During COVID-19, and more.
• Supporting Pharmacists’ Mental Health and Wellness During COVID-19: As pharmacists take on greater responsibilities during the COVID-19 pandemic they are also bearing additional physical and mental stresses as they continue to provide care to their patients. Based on our recent COVID Conversations webinar, this new practice tool encourages pharmacists to be aware of their own mental health and well being during these challenging times, and provides practical tips and links to additional resources on where to get support.

• Dipyridamole/ASA Shortage: CPhA and medSask developed this document to assist health care providers in managing patient care in the event of a shortage of dipyridamole/ASA. (April 30, 2020)
• Therapeutic alternatives to amoxicillin for common pediatric conditions: CPhA and medSask developed this document to assist health care providers in managing patient care in the event of a shortage of amoxicillin suspension. (April 29, 2020)
• COVID-19 in Patients taking disease-modifying therapy for the management of multiple sclerosis: General Considerations for management of patients with Multiple Sclerosis during COVID-19. (April 16, 2020)
• Inhaled Salbutamol Shortage: CPhA and medSask developed this document to assist health care providers in managing patient care during the current salbutamol shortage. (April 16, 2020)
• Open Access Content: COVID-19 Chapter: CPhA’s newest chapter, COVID-19, provides information for primary care practitioners on management of common symptoms such as fever, cough and headache as well as a summary of experimental treatments being used in acute-care settings. This content will be updated regularly as new evidence becomes available. (Updated May 26, 2020)
• Fluticasone Propionate Pressurized Metered Dose Inhaler Shortage: CPhA and medSask developed this document to assist health care providers in managing patient care during the current fluticasone shortage. (April 2, 2020)
• Disruption of immunization schedules during the pandemic: Is a delay a problem? During the COVID-19 pandemic, many pharmacists and other providers have stopped providing routine immunization to support reallocation of health care provider time and social distancing. (March 26, 2020)
• Treatment of COVID-19 with chloroquine or hydroxychloroquine: There is insufficient evidence that chloroquine or hydroxychloroquine will prevent COVID-19. These drugs should not be used outside the hospital setting. (Updated May 13, 2020)
• Antiretroviral combinations: The limited evidence available regarding the safety and effectiveness of these medications in the treatment of COVID-19 illness shows no benefit in severely ill patients. (Updated: May 26, 2020)
• DMARDs or other anti-rheumatic medications: To date, there is no data on COVID-19 in patients with rheumatic disease taking DMARDs. Patients should not stop taking DMARDs without the consultation of their rheumatologist. (Updated May 14, 2020)
• Use of NSAIDs in patients with COVID-19: what is the evidence? There is insufficient evidence that NSAIDs negatively impact morbidity or mortality of COVID-19 and Health Canada continues to recommend both ibuprofen and acetaminophen for treatment of fever due to COVID-19. (March 17, 2020)
• Canadian Cardiovascular Society and the Canadian Heart Failure Society guidance on cardiovascular medications: ACEi/ARB/ARNi, low-dose ASA and NSAIDs (March 20, 2020)

 

Posters

Patient Information

Pharmacists' Scope of Practice

Social Media

 

• (NEW) Pharmacists continue to have difficulty sourcing certain medications amidst the COVID-19 pandemic: Community pharmacists across Canada continue to be faced with drug supply challenges two months after the COVID-19 pandemic began, and they remain very concerned about their ability to access the medications their patients need. (May 27, 2020)
• (NEW) Remarks to the Standing Senate Committee on Social Affairs, Science and Technology: CPhA appeared before the Standing Committee on Social Affairs, Science and Technology to highlight the key role pharmacists have played throughout the pandemic. Our comments focused on the challenges pharmacists have experienced in managing drug supply, the ongoing lack of protective equipment and the need to prepare for the upcoming flu season. A video recording of the full meeting is available in both English and French. (May 20, 2020)
• (NEW) Infographic - National survey of community pharmacists and practice challenges during COVID-19: CPhA conducted a survey of Canadian community pharmacists from April 17-21, 2020 to better understanding the challenges they face on the front line of the pandemic as they care for patients.
• CPhA receives contribution surgical masks for community pharmacies: CPhA is pleased to announce the distribution of more than 200,000 surgical masks destined for community pharmacies, thanks to a generous financial contribution from Innovative Medicines Canada. (April 28, 2020)
• Statement - Pharmacists see spikes in drug shortages during pandemic: COVID-19 is and continues to be a threat to Canada’s drug supply say Canada’s pharmacists, and they are concerned about dramatic increases and volatility in the number of reported drug shortages. (April 17, 2020)
• Joint Statement - Diabetes supplies in Canada during COVID-19 crisis: CPhA and Diabetes Canada released a joint statement regarding the insulin supply in Canada to encourage Canadians to not stockpile medications or supplies. (April 8, 2020)
• Remarks to the Standing Committee on Health: CPhA appeared before the Health Committee to provide a pharmacy perspective on the COVID-19 pandemic, highlighting the crucial role front-line pharmacists are playing caring for patients, the need to protect our drug supply to avoid shortages, and the need for protections for pharmacists. (April 7, 2020)
• Statement - Supporting and recognizing pharmacists as essential health care providers during COVID-19: We urge the federal government to work immediately with provincial and territorial governments to provide pharmacists and all essential health care providers with the supports they need to continue to serve our communities. (March 25, 2020)
• Joint health stakeholder letter to First Ministers - Protecting and supporting Canada’s health-care providers during COVID-19: CPhA, along with the Canadian Medical Association, the Canadian Nurses Association, the Canadian Indigenous Nurses Association and the Canadian Association of Social Workers, sent a joint letter to Canada’s First Ministers calling for measures to provide front line health and social providers with personal protective equipment as well as clear and consistent information and guidelines. (March 23, 2020)
• Statement on 30-day supply of prescription medications: CPhA issued a statement on the need for pharmacies to carefully manage medication inventories to prevent drug shortages (March 23, 2020)
• Open letter to the Government of Canada: CPhA issued an open letter to the Government of Canada, co-signed by more than a dozen other national and provincial organizations, urging for a coordinated plan to ensure pharmacists have access to personal protective equipment (March 18, 2020)
• COVID-19 and the responsible allocation of medications to patients: To ensure that Canada’s medication supply is managed responsibly, we are recommending a 30-day supply of medications for patients, unless clinically justified (March 17, 2020)
• CPhA Statement on Stockpiling: Canadian Pharmacists Association warns against stockpiling medication in response to COVID-19 (March 4, 2020)

 

Public Health Agency of Canada

• General overview
• For health professionals
• Symptoms and treatment
• Travel advice
• Community-based measures to mitigate the spread of coronavirus disease (COVID-19) in Canada
• Risk-informed decision making for mass gatherings during COVID-19 global outbreak

World Health Organization

• Coronavirus disease (COVID-19) outbreak

International Pharmaceutical Federation

• Information for pharmacists and the pharmacy workforce